Skip to main content
Fig. 1 | Arthritis Research & Therapy

Fig. 1

From: Using real-world data to dynamically predict flares during tapering of biological DMARDs in rheumatoid arthritis: development, validation, and potential impact of prediction-aided decisions

Fig. 1

Selection of bDMARD courses from EHR data for model development. a Low disease activity was defined as a DAS28 (ESR or CRP) ≤ 3.2. b Based on the availability of at least two DAS28 measurements per year, bDMARD type and dose, disease duration, and seropositivity. bDMARD, biological disease-modifying antirheumatic drug; EHR, electronic health record; RA, rheumatoid arthritis

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us